HomeTERN • NASDAQ
Terns Pharmaceuticals Inc
add
$2.88
3.23%
After Hours:(2.78%)-0.080
$2.80
Closed: May 16, 6:57:57 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.43M | 7.79% |
Net income | -23.91M | -6.86% |
Net profit margin | — | — |
Earnings per share | -0.26 | 13.33% |
EBITDA | -27.37M | -7.92% |
Effective tax rate | -0.37% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 334.26M | 38.90% |
Total assets | 339.32M | 37.50% |
Total liabilities | 13.27M | 32.11% |
Total equity | 326.04M | — |
Shares outstanding | 87.34M | — |
Price to book | 0.75 | — |
Return on assets | -19.50% | — |
Return on capital | -20.33% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -23.91M | -6.86% |
Cash from operations | -24.44M | -7.20% |
Cash from investing | 1.96M | -75.50% |
Cash from financing | 68.00K | — |
Net change in cash | -22.42M | -51.18% |
Free cash flow | -17.55M | -10.68% |
Previous close
$2.79
Day range
$2.75 - $2.94
Year range
$1.87 - $11.40
Market cap
251.53M USD
Avg Volume
1.12M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2016
Headquarters
Website
Employees
59
